摘要
The degree to, and the mechanisms through, which stem cells are able to build, maintain, and heal the body have only recently begun to be understood. Much of the stem cell's power resides in the release of a multitude of molecules, called stem cell released molecules(SRM). A fundamentally new type of therapeutic, namely "systems therapeutic", can be realized by reverse engineering the mechanisms of the SRM processes. Recent data demonstrates that the composition of the SRM is different for each type of stem cell, as well as for different states of each cell type. Although systemsbiology has been successfully used to analyze multiple pathways, the approach is often used to develop a small molecule interacting at only one pathway in the system. A new model is emerging in biology where systems biology is used to develop a new technology acting at multiple pathways called "systems therapeutics". A natural set of healing pathways in the human that uses SRM is instructive and of practical use in developing systems therapeutics. Endogenous SRM processes in the human body use a combination of SRM from two or more stem cell types, designated as S2 RM, doing so under various state dependent conditions for each cell type. Here we describe our approach in using statedependent SRM from two or more stem cell types, S2 RM technology, to develop a new class of therapeutics called "systems therapeutics." Given the ubiquitous and powerful nature of innate S2RM-based healing in the human body, this "systems therapeutic" approach using S2 RM technology will be important for the development of anti-cancer therapeutics, antimicrobials, wound care products and procedures, and a number of other therapeutics for many indications.
The degree to, and the mechanisms through, whichstem cells are able to build, maintain, and heal the bodyhave only recently begun to be understood. Much of thestem cell＇s power resides in the release of a multitudeof molecules, called stem cell released molecules （SRM）.A fundamentally new type of therapeutic, namely＂systems therapeutic＂, can be realized by reverseengineering the mechanisms of the SRM processes.Recent data demonstrates that the composition of theSRM is different for each type of stem cell, as well asfor different states of each cell type. Although systemsbiology has been successfully used to analyze multiplepathways, the approach is often used to develop a smallmolecule interacting at only one pathway in the system.A new model is emerging in biology where systemsbiology is used to develop a new technology actingat multiple pathways called ＂systems therapeutics＂. Anatural set of healing pathways in the human that usesSRM is instructive and of practical use in developingsystems therapeutics. Endogenous SRM processes inthe human body use a combination of SRM from twoor more stem cell types, designated as S2RM, doing sounder various state dependent conditions for each celltype. Here we describe our approach in using statedependentSRM from two or more stem cell types,S2RM technology, to develop a new class of therapeuticscalled ＂systems therapeutics.＂ Given the ubiquitous andpowerful nature of innate S2RM-based healing in thehuman body, this ＂systems therapeutic＂ approach usingS2RM technology will be important for the developmentof anti-cancer therapeutics, antimicrobials, woundcare products and procedures, and a number of othertherapeutics for many indications.
